Continuing Metformin throughout pregnancy in women with polycystic ovary syndrome safely reduces first trimester miscarriage from 64% to 5%, without teratogenicity.

被引：0
|
作者：
Glueck, CJ [1 ]
Phillips, H [1 ]
Cameron, D [1 ]
Sieve-Smith, L [1 ]
Wang, P [1 ]
Wang, P [1 ]
机构：
[1] Jewish Hosp Cincinnati, Ctr Cholesterol, Cincinnati, OH 45229 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2000年 / 48卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
174
引用
收藏
页码：263A / 263A
页数：1
相关论文
共 29 条
  • [1] Metformin throughout pregnancy in women with polycystic ovary syndrome reduces first trimester miscarriage from 45% to 9%.
    Glueck, CJ
    Phillips, H
    Cameron, D
    Tracy, T
    Sieve-Smith, L
    Wang, P
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (02) : 188A - 188A
  • [2] Metformin throughout pregnancy in women with polycystic ovary syndrome reduces first trimester miscarriage from 45% to 9%.
    Glueck, CJ
    Phillips, H
    Cameron, D
    Tracy, T
    Sieve-Smith, L
    Wang, P
    [J]. FASEB JOURNAL, 2000, 14 (04): : A778 - A778
  • [3] Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study
    Glueck, CJ
    Phillips, H
    Cameron, D
    Sieve-Smith, L
    Wang, P
    [J]. FERTILITY AND STERILITY, 2001, 75 (01) : 46 - 52
  • [4] Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome
    Glueck, CJ
    Wang, P
    Kobayashi, S
    Phillips, H
    Sieve-Smith, L
    [J]. FERTILITY AND STERILITY, 2002, 77 (03) : 520 - 525
  • [5] Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome
    Begum, Mosammat Rashida
    Khanam, Nurun Nahar
    Quadir, Ehsan
    Ferdous, Jannatul
    Begum, Mosammat Sahina
    Khan, Farzana
    Begum, Anowara
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2009, 35 (02) : 282 - 286
  • [6] Metformin throughout pregnancy in women with polycystic ovary syndrome: safety and advantages
    Dalal, R.
    Pai, H.
    Palshetkar, N.
    Takhtani, M.
    Bansal, B.
    Saxena, N.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 21 - 21
  • [7] Metformin therapy throughout pregnancy in women with polycystic ovary syndrome reduces development of gestational diabetes from 32-56% to 3%
    Glueck, CJ
    Wang, P
    Kobayashi, S
    Phillips, H
    Sieve-Smith, L
    [J]. CIRCULATION, 2001, 104 (17) : 831 - 832
  • [8] Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women:: results of a randomized study
    Vanky, E
    Salvesen, KÅ
    Heimstad, R
    Fougner, KJ
    Romundstad, P
    Carlsen, SM
    [J]. HUMAN REPRODUCTION, 2004, 19 (08) : 1734 - 1740
  • [9] The role of continuing metformin therapy during pregnancy in the reduction of gestational diabetes and improving pregnancy outcomes in women with polycystic ovary syndrome
    Abd El Hameed, Azza A.
    Shreif, Hala E.
    Mowafy, Hala E.
    [J]. MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2011, 16 (03) : 204 - 208
  • [10] Coagulation and Fibrinolytic Indices During the First Trimester of Pregnancy in Women With Polycystic Ovary Syndrome: A Preliminary Study
    Yu Shan
    Aiming Wang
    Ying Sun
    Wen Jiang
    Baosen Pang
    Zhiyuan An
    Xin Du
    Wei Wang
    Zhongwei Huang
    [J]. Reproductive Sciences, 2013, 20 : 1390 - 1397
123